John Gordon Freund's Net Worth

$329 Million

Estimate Recalculated Feb 28, 2024 04:26PM EST

Who is John Gordon Freund?

John Gordon Freund has an estimated net worth of $329 Million. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, MAKO Surgical Corp., MAP Pharmaceuticals, Inc., TETRAPHASE PHARMACEUTICALS INC, Targanta Therapeutics Corp., Sirtris Pharmaceuticals, Inc., SI-BONE, Inc., COLLEGIUM PHARMACEUTICAL, INC, SUTRO BIOPHARMA, INC., CONCERT PHARMACEUTICALS, INC., PROTEON THERAPEUTICS INC, ACELRX PHARMACEUTICALS INC, XENOPORT INC, and HANSEN MEDICAL INC.

SEC CIK

John Gordon Freund's CIK is 0001296771

Past Insider Trading and Trends

2014 was John Gordon Freund's most active year for acquiring shares with 25 total transactions. John Gordon Freund's most active month to acquire stocks was the month of April. 2014 was John Gordon Freund's most active year for disposing of shares, totalling 44 transactions. John Gordon Freund's most active month to dispose stocks was the month of September. 2007 saw John Gordon Freund paying a total of $52,269,192.13 for 5,478,526 shares, this is the most they've acquired in one year. In 2013 John Gordon Freund cashed out on 46,410,704 shares for a total of $83,441,831.24, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.14%
-37.53K
$26.02
-$976,582.64
1.72M
Scheduled
Feb 20
Form 4
1.73M
$15.00
1.73M
Feb 4
Form 3/A
0
0
No matching records found

Targanta Therapeutics Corp. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.22M
0
Feb 25
Form 3
0
0
No matching records found

SI-BONE, Inc. (SIBN) Snapshot price: $20.6

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-22.40%
-30.00K
$20.54
-$616,197.00
103.9K
Aug 9
Form 4
+23.21%
4.87K
25.84K
Jun 9
Form 4
+65.83%
8.32K
20.97K
Jun 16
Form 4
-13.58%
-52.09K
$31.24
-$1,627,300.87
331.37K
Jun 14 - Jun 16
Form 4
+43.74%
3.85K
12.64K
Jun 10
Form 4
-15.73%
-71.59K
$30.38
-$2,174,967.74
383.46K
May 27 - May 28
Form 4
-13.31%
-69.86K
$32.37
-$2,261,538.29
455.05K
May 24 - May 26
Form 4
-57.88%
-721.25K
$30.38
-$21,913,571.65
524.91K
Mar 16 - Mar 17
Form 4
-15.92%
-235.89K
$31.13
-$7,343,186.27
1.25M
Mar 11 - Mar 15
Form 4
-9.07%
-147.89K
$23.32
-$3,448,677.20
1.48M
Dec 2 - Dec 3
Form 4
-8.19%
-190.05K
$22.00
-$4,181,166.00
2.13M
Oct 19
Form 4
-26.18%
-1.00M
$21.50
-$21,500,000.00
2.82M
Jan 27
Form 4
8.8K
8.8K
Jun 16
Form 4
-3.84%
-152.42K
$18.40
-$2,805,180.81
3.82M
Aug 26
Form 4
-0.59%
-47.58K
$20.15
-$958,469.62
7.97M
Aug 21 - Aug 23
Form 4
-9.05%
-400.00K
$18.25
-$7,300,000.00
4.02M
Aug 12
Form 4
0
0
Jun 13
Form 4
4.42M
$15.00
4.42M
Oct 19
Form 4
4.42M
$15.00
4.42M
Oct 19
Form 3
0
0
Form 3
0
0
No matching records found

CONCERT PHARMACEUTICALS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+3,634.46%
1.18M
$14.00
1.21M
Feb 20
Form 3
0
0
Form 3
0
0
No matching records found

PROTEON THERAPEUTICS INC (TARA) Snapshot price: $2.72

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+47.79%
703.59K
$0.99
$699,999.70
2.18M
Nov 8
Form 4
0
0
Jun 8
Form 4
0
0
Jun 22
Form 4
0
0
Jun 20
Form 4
0
0
Jun 9
Form 4
0
0
Jun 2
Form 4
1.43M
$8.98
-$560,380.00
1.43M
Oct 27
Form 4
1.43M
$8.98
-$560,380.00
1.43M
Oct 27
Form 3
0
0
Form 3
0
0
No matching records found